1. Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinoma
   Shijing Yu et al, 2023, Asian Journal of Pharmaceutical Sciences CrossRef
2. METTLing in Stem Cell and Cancer Biology
   John G. Tooley et al, 2023, Stem Cell Reviews and Reports CrossRef
3. tRNA modifications: insights into their role in human cancers
   Ye Wang et al, 2023, Trends in Cell Biology CrossRef
4. The role of dysregulated mRNA translation machinery in cancer pathogenesis and therapeutic value of ribosome-inactivating proteins
   Wentao Jia et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
5. Correlation Between the RNA Methylation Genes and Immune Infiltration and Prognosis of Patients with Hepatocellular Carcinoma: A Pan-Cancer Analysis
   Xin-Yu Li et al, 2022, Journal of Inflammation Research CrossRef
6. Prognostic analysis and risk assessment based on RNA editing in hepatocellular carcinoma
   Xintong Shi et al, 2024, Journal of Applied Genetics CrossRef
7. The role of RNA modification in hepatocellular carcinoma
   Qiang Feng et al, 2022, Frontiers in Pharmacology CrossRef
8. Advancements of the CRISPR/Cas9 System in the Treatment of Liver Cancer
   Zhuoyu Li et al, 2024, Current Protein & Peptide Science CrossRef
9. Comprehensive Analysis of METTLs (METTL1/13/18/21A/23/25/2A/2B/5/6/9) and Associated mRNA Risk Signature in Hepatocellular Carcinoma
   Haoyu Wang et al, 2023, Analytical Cellular Pathology CrossRef
10. The impact of tRNA modifications on translation in cancer: identifying novel therapeutic avenues
    Ana M Añazco-Guenkova et al, 2024, NAR Cancer CrossRef